TAO WANG to Combined Modality Therapy
This is a "connection" page, showing publications TAO WANG has written about Combined Modality Therapy.
Connection Strength
0.089
-
The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy. Jpn J Clin Oncol. 2011 Nov; 41(11):1244-50.
Score: 0.068
-
A phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancer. Oncologist. 2015 Jan; 20(1):13.
Score: 0.021